2158-82-9Relevant articles and documents
Tetrahydroisoquinoline compounds
-
, (2021/10/13)
The present invention provides a substituted aryl compound represented by the formula (I) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition and containing the same as PRMT5 inhibitor.
HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
Paragraph 00569, (2013/03/26)
Compounds and pharmaceutical compositions of formulae (I), (XI) and (XII) as PI3 kinase modulators and their use in the treatment of diseases such as cancer.